HAOCommunication Services · Advertising AgenciesHAO Stock Forecast: Haoxi Health Technology Ltd. Price Predictions for 2026-2027
Ticker Nerd's systematic factor model, run across ~4,600 US stocks, ranks it 6 of 100 as at 1 Aug 2026 — in the weakest quartile.
HAO stock analysis: one number for the whole business
Consensus tells you what everyone already believes. The model scores Haoxi Health Technology Ltd. on its factor families — the same systematic rank behind the Ticker Nerd portfolio.
Percentile across ~4,600 US stocks on Ticker Nerd’s systematic factor model. Higher is better. How the model is built and tested
Size (100): Smaller than most of the companies we track.
Momentum (5): The shares have been drifting down relative to others.
The rank is the raw material. Whether the rules would actually own Haoxi Health Technology Ltd. — and when they’d sell — is the membership.
HAO stock forecast 2026-2027: analyst price targets & predictions
The bullish and bearish analyst opinions on HAO, reported as data — targets and ratings, the market's view beside the model's.
We don’t hold enough price history for this company yet.
Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.
HAO analyst estimate revisions
Not the forecast itself — the direction analysts are revising it. Revision direction is one of the model's factor families.
Haoxi Health Technology Ltd. (HAO) financial data
A margin means little on its own. Each bar marks where the figure sits across the whole US universe we score.
- Trailing P/E
- 0.0×
- Price / sales
- 0.0×
- Price / book
- 0.0×
- EV / EBITDA
- 0.7×
Cheaper than 74% of US stocks
Cheaper than 99% of US stocks
Cheaper than 92% of US stocks
Cheaper than 58% of US stocks
- Revenue growth (YoY)
- 41.2%
- Earnings growth (YoY)
- —
- Gross margin
- —
- Operating margin
- −16.8%
- Net margin
- −6.5%
Higher than 84% of US stocks
Higher than 23% of US stocks
Higher than 22% of US stocks
- Return on equity
- −16.0%
- Return on assets
- −22.1%
- Dividend yield
- 24.0%
Higher than 33% of US stocks
Higher than 18% of US stocks
Higher than 95% of US dividend payers
Bars mark the percentile across the ~4,600 US stocks Ticker Nerd covers, among those reporting the figure.
HAO vs competitors
The nearest names by industry and size, scored by the same model — like for like.
This page is one stock. Monday covers all of them.
Computed off the Friday close and sent before the US open.
Market Radar reports the week’s largest rank changes across roughly 4,600 US stocks, the factor behind each one, and where the market went. HAO appears on the weeks it earns a place.
Frequently asked questions about HAO stock
How does Ticker Nerd's model rank HAO?
As at 1 Aug 2026, Haoxi Health Technology Ltd. ranks 6 out of 100 on Ticker Nerd's systematic factor model — a percentile across roughly 4,600 US stocks, built from its factor families. Its strongest factor family is Size (100 of 100).
What is the HAO stock forecast for 2030?
No analyst covering Haoxi Health Technology Ltd. publishes a 2030 price target — Wall Street targets run 12 to 18 months out. Sites quoting a 2030 price for HAO are extrapolating price history, which says nothing about the business.
What does Haoxi Health Technology Ltd. do?
Haoxi Health Technology Ltd. is a holding company that provides digital marketing solutions in China, with a client base concentrated in the healthcare and medical aesthetics industries.
About Haoxi Health Technology Ltd.
Haoxi Health Technology Ltd. is a holding company that provides digital marketing solutions in China, with a client base concentrated in the healthcare and medical aesthetics industries. The company focuses on online short video and social-media-based advertising, offering integrated services that span campaign planning, creative content production, media placement, and ongoing data-driven optimization. Haoxi Health Technology distributes advertisements through major Chinese platforms such as Douyin, Toutiao, WeChat, and Sina Weibo via media partners, aiming to help advertisers acquire, convert, and retain consumers across these channels. Its role in the market is centered on connecting healthcare-related advertisers with targeted digital audiences, leveraging performance-oriented marketing techniques and closed-loop campaign management. Founded in 2018 and headquartered in Beijing, China, Haoxi Health Technology operates within the communication services sector, specifically the advertising and online marketing segment, serving as a specialized intermediary between healthcare brands and the country’s large and highly engaged mobile internet user base.
CEO Mr. Zhen Fan · 26 employees · China · https://www.haoximedia.com